Clifford J. Steer is a Professor of Medicine and Genetics, Cell Biology and Development at the University of Minnesota Medical School, Minneapolis, MN. He is a member of the Stem Cell Institute, Masonic Cancer Center, Institute for Engineering in Medicine and the Lillehei Heart Institute. He received his MD from the University of Minnesota. He accepted a Hepatology Fellowship at the NIH in the Section on Diseases of the Liver in 1976 and remained on staff at the NIH as an expert in his field for an additional 10 years. In 1989, he returned to the University of Minnesota as a Professor in the Departments of Medicine and Genetics, Cell Biology and Development. Throughout his career, he has developed expertise in various disciplines including epigenetics, microRNAs, receptor-mediated endocytosis, non-viral gene therapy and gene editing. Much of his research has focused on liver regeneration and neurodegenerative disorders, including Huntington’s disease, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. His present research is on developing human livers in pigs via genetic engineering and blastocyst complementation to address the enormous shortage of livers for transplantation.
Research Keywords & Expertise
Genome editing
liver regeneration
microRNA biogenesis
Receptor-mediated deli...
Short Biography
Clifford J. Steer is a Professor of Medicine and Genetics, Cell Biology and Development at the University of Minnesota Medical School, Minneapolis, MN. He is a member of the Stem Cell Institute, Masonic Cancer Center, Institute for Engineering in Medicine and the Lillehei Heart Institute. He received his MD from the University of Minnesota. He accepted a Hepatology Fellowship at the NIH in the Section on Diseases of the Liver in 1976 and remained on staff at the NIH as an expert in his field for an additional 10 years. In 1989, he returned to the University of Minnesota as a Professor in the Departments of Medicine and Genetics, Cell Biology and Development. Throughout his career, he has developed expertise in various disciplines including epigenetics, microRNAs, receptor-mediated endocytosis, non-viral gene therapy and gene editing. Much of his research has focused on liver regeneration and neurodegenerative disorders, including Huntington’s disease, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. His present research is on developing human livers in pigs via genetic engineering and blastocyst complementation to address the enormous shortage of livers for transplantation.